baber/WOPTO huggingface dataset:
Patent FI-965005-A0 (FI)
Inventor: KJELDSEN THOMAS BOERGLUM
IPC: C12N1/19
Filed: 1996-12-13
Abstract: The present invention relates to a DNA expression cassette comprising the following sequence: 5'-P-SP-LS-PS-*gene*-(T)i-3'wherein P is a promoter sequence, SP is a DNA sequence encoding a signal peptide, LS is a DNA sequence encoding a leader peptide of formula I: GinProIle(Asp/Glu)(Asp/Glu)X1(Glu/Asp)X2AsnZ(Thr/Ser)X3 (SEQ ID NO: 77) (I) wherein X1 is a peptide bond or a codable amino acid; X2 is a peptide bond, a codable amino acid or a sequence of up to 4 codable amino acids which may be the same or different; Z is a codable amino acid except Pro; and X3 is a sequence of from 4 to 30 codable amino acids which may be the same or different; PS is a DNA sequence encoding a processing site; *gene* is a DNA sequence encoding a polypeptide; T is a terminator sequence; and i is 0 or 1.
Patent FI-973407-A0 (FI)
Inventor: LOEFGREN KRISTINA
IPC: A41D31/00
Filed: 1997-08-20
Abstract: PCT No. PCT/SE96/00222 Sec. 371 Date Sep. 18, 1997 Sec. 102(e) Date Sep. 18, 1997 PCT Filed Feb. 20, 1996 PCT Pub. No. WO96/25863 PCT Pub. Date Aug. 29, 1996The present invention relates to a plastic surgical coat. According to the invention, the coat is comprised at least partially of a plastic material having a pattern of projections which extend out from the inside of the coat to facilitate air circulation through a space between an interior surface of the coat and the body of the wearer.
Patent AP-9400665-A0 (AP)
Title: Forward flow freeing winnower tobacco separator.
Inventor: WOODFORD WILLIAM ALFRED
Filed: 1994-08-19
Abstract: A winnower separator in which
Patent AP-9400687-A0 (AP)
Title: Process for the electrochemical dissolution of sulfur-containing and/or concentrated minerals by ion-exchange membranes and potential difference.
Inventor: TSCHISCHOW NIKOLAUS
IPC: C25C1/06
Filed: 1994-10-13
Abstract: The invention discloses a process for benefication of sulphur containing metallic ores or concentrates by a combination of ion-exchange and electrodeposition in a closed-circuit multiple-cell plant.
Patent IL-64104-A0 (IL)
Title: Scanning mirror arrangement
IPC: G01J1/04
Filed: 1981-10-23
Abstract: The scanning mechanism comprises a vertical-scan reflector (21) which reflects radiant energy transmitted along a first optical path (28) from an object field, and a horizontal-scan reflector (22) which is arranged to receive the radiant energy reflected by the vertical-scan reflector and reflect it back onto the vertical-scan reflector at a different angle so that the radiant energy, upon its second incidence on the vertical-scan reflector, is reflected via a fixed reflector (23), along a second optical path (29) in a different plane from the first optical path. The reflectors are oscillated about axes (24,25) substantially orthogonal with respect to one another. The vertical-scan reflector axis (24) is substantially perpendicular to the first optical path (28) whilst the horizontal-scan reflector axis (25) is substantially perpendicular to the incident radiant energy reflected from the vertical-scan reflector. A detector (30) is positioned to receive radiant energy reflected along the second optical path. The disposition of the axes (24,25) of the reflectors provides a distortion free image signal for the detector which is comparable with the x-y scan pattern of a conventional television display circuit.
Patent IL-66152-A0 (IL)
Title: Pyridinocarbinols,their preparation and their use as fungicides
IPC: A01N43/40
Filed: 1982-06-28
Abstract: Pyridinecarbinols of the formula    <IMAGE>  I  where R1 is hydrogen or alkyl, R2 is alkyl or alkenyl, and R3, R4 and R5 are hydrogen, chlorine, bromine, fluorine or alkyl, plant-physiologically tolerated addition salts of these compounds with acids, and fungicides containing these compounds.
Patent IL-70528-A0 (IL)
Title: Pharmaceutical compositions comprising derivatives of naphthaleneor azanaphthalenecarboxamide,novel derivatives of such compounds and processes for their preparation
IPC: C07D211/26
Filed: 1983-12-22
Abstract: Compounds of the formula:    <IMAGE>  (I)  in which R1 is C1-6 alkyl, phenyl, C3-6 cycloalkyl, phenylalkyl, cycloalkyl-alkyl or   <IMAGE> R3 and R4 being H or alkyl, R5 being alkenyl or alkynyl, and the sum of the carbon atoms in R3, R4 and R5 being 2 to 5, R2 is as defined for R1 and may also represent   <IMAGE>  in which n is 0, 1, 2 or 3, it also being possible for R1 and R2 to form, with the nitrogen atom to which they are attached, a 5-, 6- or 7-membered heterocyclic radical which can contain another hetero-atom chosen from O and N and which can carry 1 or 2 substituents, Z is phenyl, pyridinyl, thienyl, thiazol-2-yl or substituted phenyl, X and R0 are H, halogen, C1-3 alkyl, C1-3 alkoxy, nitro or CF3, A represents N or CH and E represents N or CH, some of which are known compounds, are therapeutically useful compounds useful in the treatment of anxiety states or of pulmonary, renal, circulatory or cardiovascular disorders.
Patent IL-75031-A0 (IL)
Title: Phenol derivatives
IPC: C07D231/44
Filed: 1985-04-26
Abstract: A phenol derivative of the formulawherein NU is a defined bis-phenolic nucleus including a hydroxyphenyl-hydroxynaphthyl; hydroxyphenyl-hydroxyin- danyl, hydroxyphenyl-hydroxybenzothienyl or di-hydroxyphenyl-ethylene or vinylene nucleus; wherein A is alkylene, alkenylene or cycloalkylene which is interrupted by a heterocyclene linkage, wherein R<sup>1</sup> is hydrogen, or alkyl, alkenyl, cycloalkyl, halogenoalkyl, aryl or arylalkyl, or R is joined to R<sup>2</sup>, and wherein X is -CONR<sup>2-</sup>, -CSNR<sup>2-</sup>, -NR<sup>12</sup>CO-, -NR<sup>12</sup>CS-, -NR<sup>12</sup>CONR<sup>2</sup>-,-SO<sub>2</sub>NR<sup>2</sup>- or -CO-, or, when R<sup>1</sup> is not hydrogen, is -NR<sup>12</sup>COO-, -S-, -SO- or -S0<sub>2</sub>-, wherein R<sup>2</sup> is hydrogen or alkyl, or R<sup>1</sup> and R<sup>2</sup> together form alkylene; wherein R<sup>12</sup> is hydrogen or alkyl, and wherein R<sup>22</sup> is hydrogen, cyano or nitro; or a salt thereof when appropriate. The compounds possess antioestrogenic activity and may be used for the treatment of hormone-dependent breast tumours or of anovulatory infertility.
Patent IL-76465-A0 (IL)
Title: Unsaturated polysiloxanes,polymerizable compositions thereof and contact lenses made therefrom
IPC: C08F290/14
Filed: 1985-09-23
Abstract: Polysiloxanes of uniform molecular weight (MW) distribution with 500-10,000 MW segments of polysiloxane and containing at least one vinyl group connected to said polysiloxane segments through intervening alkylene-urea or -urethane linkages are prepared from polysiloxane-polyols, -polyamines or -polythiols by reaction with an unsaturated compound containing an isocyanato moiety, for example 2-isocyanatoethyl methacrylate. The polysiloxanes containing the vinyl groups are useful as radiation- or thermally curable coatings for glass, textiles, plastics, wood, ceramics, metals, as films or bandages for medicinal purposes, or molded shapes, in form of contact lenses, catheters or implants, either by themselves or in combination with other vinyl monomers; and are particularly useful in preparing hard or soft contact lenses, including hydrogel contact lenses.
Patent IL-84361-A0 (IL)
Title: Preparation of core-shell particle dispersions
IPC: C09D151/00
Filed: 1987-11-03
Abstract: An aqueous dispersion of water-insoluble core-shell particles is prepared by emulsion polymerization for use as an opacifying agent in coatings. The particles have interior cores which are swollen with nonaqueous solvent. The polymeric exterior shells have a glass transition temperature greater than about 50 DEG C in the presence of the nonaqueous solvent. The partition coefficient for the nonaqueous solvent between the interior core polymer phase and the exterior shell polymer phase is at least about 1.25. Coatings compositions formulated using the core-shell particles show increased opacity, as single light scattering microvoids are formed in individual particles when the solvent evaporates and the core collapses inside the rigid exterior shell. Opacity develops even when aqueous coatings containing the particles are dried under high humidity conditions.
Patent IL-85828-A0 (IL)
Title: Automatic two-chamber injector
IPC: A61M5/20
Filed: 1988-03-23
Abstract: The invention relates to an automatic two-chamber injector for mixing and injecting a medical solution. The injector comprises a barrel (11) having a first end with a receiving portion (15) for an injection needle (17), said portion being sealed prior to use, and a second end with a displaceable plunger (27). The barrel (11) comprises two chambers (29, 30) separated by a migrationproof membrane (28), said membrane (28) being adapted to rupture when the plunger (27) is displaced towards the first end of the barrel (11). The invention also relates to a method for mixing and injecting a solution by means of an automatic two-chamber injector and to a cartridge for a two-chamber injector.
Patent FI-20010311-A0 (FI)
IPC: A61B5/0408
Filed: 2001-02-19
Abstract: The invention relates to a sensor (42) placed on the skin, which can advantageously be integrated in a garment and has a contact layer in contact with the skin containing conductive fibres for receiving signals and a moisture retentive moisture layer (41) on top of the contact layer.
Patent FI-20011913-A0 (FI)
Inventor: LEINONEN MIKA
IPC: H04Q7/38
Filed: 2001-09-28
Abstract: A communication system comprising means (102A to 102B) for receiving messages according to a control protocol from terminals (100A to 100D) using the communication system, the control protocol including a registration message intended for updating the location of a terminal user. Said reception means (102A to 102B) are arranged to receive management information concerning a user group in said registration message, the communication system further comprising management means (102A to 102B) for managing the user group on the basis of the management information received.
Patent IL-103856-A0 (IL)
Title: Aminoalkyl-substituted 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
IPC: C07D223/20
Filed: 1992-11-24
Abstract: The invention relates to aminoalkyl-substituted 5,6-dihydrodibenz[b,e]azepine-6,11-dione-11-oximes, processes for their preparation and their use as antiretroviral agents.
Patent IL-104358-A0 (IL)
Title: Radiological imaging method and contrast agent
Inventor: FISHMAN ROYCE SHAWN
IPC: A61K51/00
Filed: 1993-01-11
Abstract: A radiological imaging method employing a contrast enhancement agent comprising stable xenon, oxygen and helium, for use with computerized two and three dimensional X-Ray systems and software used with said systems, in the imaging and quantitative measurement of pulmonary ventilation, patency of, distribution of and gas flow in the trachea, bronchi, bronchioles and alveoli, evaluation and optimization of respiratory therapy gas mixtures and pressures separately and in combination, liver blood flow, renal blood flow, cerebral blood flow and brain tissue function. <IMAGE>
Patent IL-108534-A0 (IL)
Title: Accident data store
IPC: B62D41/00
Filed: 1994-02-03
Abstract: In order to record accidents caused to parked vehicles, for example by other cars, the invention provides that an accident data memory installed in the parked vehicle is extended by means which, preferably after a certain time-lag after switching off the engine, maintain the accident data memory of the vehicle operative for a limited time with a sensitivity which is greater than that prevailing when the vehicle engine is switched on, in constant readiness for the detection and recording of an accident situation.
Patent IL-109077-A0 (IL)
Title: Preparation of halomethylbenzoyl cyanides and certain such novel compounds
IPC: C07C253/14
Filed: 1994-03-22
Abstract: A process for preparing halomethylbenzoyl cyanides I Ph-CO-CNI (Ph=phenyl radical substituted by chloromethyl or bromomethyl which, if desired, can additionally carry 1-4 further radicals) by reacting halomethylbenzoyl chlorides II Ph-CO-ClII with an alkali metal cyanide or transition metal cyanide, if appropriate in an organic diluent, and novel halomethylbenzoyl cyanides I'     <IMAGE>  I'  (X=halogen, C1-C4-alkyl, C1-C4-alkoxy, CF3, C1-C5-alkyl-(C1-C5-alkyl)hydroxyimino or C1-C5-alkyl-(C2-C5-alkenyl)hydroxyimino; m=0 to 4 and Y=chloromethyl or bromomethyl) are described. The halomethylbenzoyl cyanides I are important intermediates for the synthesis of plant protection agents.
Patent IL-122541-A0 (IL)
Title: Casing which includes a clamping member
IPC: H02G15/076
Filed: 1996-07-12
Abstract: PCT No. PCT/GB96/01652 Sec. 371 Date Mar. 2, 1996 Sec. 102(e) Date Mar. 2, 1996 PCT Filed Jul. 12, 1996 PCT Pub. No. WO97/04345 PCT Pub. Date Feb. 6, 1997A casing, e.g. for a cable splice closure, includes: (a) first and second parts, each of which has a peripheral flange, and (b) a clamping member in the form of a split ring which, in use, is placed around the flanges of the first and second parts and thereby clamps the parts together, at least part of the clamping member being formed as a single flexible piece which may be flexed open to allow the clamping member to be placed around the flanges of the first and second parts.
Patent IL-129123-A0 (IL)
Title: 1,4-Disubstituted piperazines
IPC: A61P25/06
Filed: 1997-10-02
Abstract: The present invention relates to 1,4-disubstituted piperazines of the general formula wherein X, Y, Z, R1, R2 and r are as defined in the detailed part of the present description or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation as well as their use for the treatment of indications caused by or related to the secretion and circulation of insulin antagonising peptides, e.g. non-insulin-dependent diabetes mellitus (NIDDM) and ageing-associated obesity.
Patent IL-130861-A0 (IL)
Title: Methods for closing suturable wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent
IPC: A61L26/00
Filed: 1998-01-12
Abstract: Disclosed are cyanoacrylate compositions comprising a compatible antimicrobial agent and, in particular, a compatible iodine containing antimicrobial agent. These compositions provide for in situ formation of an antimicrobial polymeric cyanoacrylate film on mammalian skin.
Patent IL-130876-A0 (IL)
Title: Eukaryotic gene expression cassette and uses thereof
IPC: A61P25/00
Filed: 1998-01-12
Abstract: An expression cassette comprising a herpes simplex virus latency-associated transcript P2 region, a promoter and a heterologous gene operably linked in that order. The expression cassette is incorporated into herpes simplex virus vectors to allow for delivery of heterologous genes to mammalian cells for long-term expression.
Patent IL-137316-A0 (IL)
Title: Cutting tool assembly
IPC: B23B31/11
Filed: 2000-07-16
Abstract: The present invention provides a cutting tool assembly having a tool shank with an elongated hole extending axially through the tool shank. An elongated support bar having threaded bore at its forward end is retained in the elongated hole. A cutting head having a forward cutting portion and a rear threaded portion is retained in the support bar with its rear threaded portion threadingly engaged with the threaded bore in the forward end of the support bar.
Patent IL-140759-A0 (IL)
Title: Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies
IPC: A61P43/00
Filed: 1999-07-05
Abstract: Vitamin E and esters thereof, in particular Vitamin E acetate, are used in the manufacture of a medicament for the topical treatment of mucosal pathology, such as dryness of the oral mucosa, dryness and itching of the vaginal, rectal, nasal and eye mucosa, aphthous ulcers, stomatitis, glossitis, keratoconjunctivis, keratitis, keratalgia, corneal ulcers, corneal de-epithelization, encrusted rhinitis, nasal vestibulitis, epistaxis, atrophic vaginitis, cervical ectropion, follicular vulvitis, erythematous vulvitis, radiation-related vulvitis, genital herpes, pruritus ani, fecal incontinence, proctitis and ulcerous proctitis.
Patent IL-153305-A0 (IL)
Title: Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
IPC: C07D333/24
Filed: 1996-08-23
Abstract: The invention provides a compound of the formula <CHEM>     wherein X is S, O, NR' where R' is H or alkyl of 1 to 6 carbons, or   X is ÄC(R1)2Ün where R1 is independently H or alkyl of 1 to 6 carbons, and n is an integer between 0 and 2; R2 is hydrogen, lower alkyl of 1 to 6 carbons, F, Cl, Br, I, CF3, fluoro substituted alkyl of 1 to 6 carbons, OH, SH, alkoxy of 1 to 6 carbons, or alkylthio of 1 to 6 carbons;   R3 is hydrogen, lower alkyl of 1 to 6 carbons or F;   m is an integer having the value 0-3;   o is an integer having the value 0-3; Y is a phenyl or naphthyl group, or heteroaryl selected from a group consisting of pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, oxazolyl, imidazolyl and pyrrazolyl, said phenyl and heteroaryl groups being optionally substituted with one or two R2 groups; A is (CH2)q where q is 0-5, lower branched chain alkyl having 3-6 carbons, cycloalkyl having 3-6 carbons, alkenyl having 2-6 carbons and 1 or 2 double bonds, alkynyl having 2-6 carbons and 1 or 2 triple bonds; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR8, CONR9R10, -CH2OH, CH2OR11, CH2OCOR11, CHO, CH(OR12)2, CHOR13O, -COR7, CR7(OR12)2, CR7OR13O, or tri-lower alkylsilyl, where R7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R8 is an alkyl group of 1 to 10 carbons or trimethylsilylalkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R8 is phenyl or lower alkylphenyl, R9 and R10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl or lower alkylphenyl, R11 is lower alkyl, phenyl or lower alkylphenyl, R12 is lower alkyl, and R13 is divalent alkyl radical of 2-5 carbons, and R14 is (R15)r-phenyl, (R15)r-naphthyl, or (R15)r-heteroaryl where the heteroaryl group has 1 to 3 heteroatoms selected from the group consisting of O, S and N, r is an integer having the values of 0-5, and R15 is independently H, F, Cl, Br, I, NO2, N(R8)2, N(R8)COR8, NR8CON(R8)2, OH, OCOR8, OR8, CN, an alkyl group having 1 to 10 carbons, fluoro substituted alkyl group having 1 to 10 carbons, an alkenyl group having 1 to 10 carbons and 1 to 3 double bonds, alkynyl group having 1 to 10 carbons and 1 to 3 triple bonds, or a trialkylsilyl or trialkylsilyloxy group where the alkyl groups independently have 1 to 6 carbons;   R16 is H, lower alkyl of 1 to 6 carbons;   R17 is H, lower alkyl of 1 to 6 carbons, OH or OCOR11, and p is zero or 1, with the proviso that when p is 1 then there is no R17 substituent group, and m is an integer between 0 and 2.
Patent IL-158760-A0 (IL)
Title: Method and apparatus for allocating resources in a multiple-input multiple-output (mimo) communication system
IPC: H04L1/00
Filed: 2002-05-15
Abstract: Techniques to schedule downlink data transmission to a number of terminals in a wireless communication system. In one method, one or more sets of terminals are formed for possible data transmission, with each set including a unique combination of one or more terminals and corresponding to a hypothesis to be evaluated. One or more sub-hypotheses may further be formed for each hypothesis, with each sub-hypothesis corresponding to specific assignments of a number of transmit antennas to the one or more terminals in the hypothesis. The performance of each sub-hypothesis is then evaluated, and one of the evaluated sub-hypotheses is selected based on their performance. The terminal(s) in the selected sub-hypothesis are then scheduled for data transmission, and data is thereafter coded, modulated, and transmitted to each scheduled terminal from one or more transmit antenna assigned to the terminal.